Cargando…

Long-Term GAD-alum Treatment Effect on Different T-Cell Subpopulations in Healthy Children Positive for Multiple Beta Cell Autoantibodies

OBJECTIVE: The objective of this study was to explore whether recombinant GAD65 conjugated hydroxide (GAD-alum) treatment affected peripheral blood T-cell subpopulations in healthy children with multiple beta cell autoantibodies. METHOD: The Diabetes Prevention–Immune Tolerance 2 (DiAPREV-IT 2) clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salami, Falastin, Spiliopoulos, Lampros, Maziarz, Marlena, Lundgren, Markus, Brundin, Charlotte, Bennet, Rasmus, Hillman, Magnus, Törn, Carina, Elding Larsson, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159828/ https://www.ncbi.nlm.nih.gov/pubmed/35664355 http://dx.doi.org/10.1155/2022/3532685

Ejemplares similares

Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA
por: Martinez, Maria Månsson, et al.
Publicado: (2022)

Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA
por: Martinez, Maria Månsson, et al.
Publicado: (2020)

Complete blood counts with red blood cell determinants associate with reduced beta‐cell function in seroconverted Swedish TEDDY children
por: Salami, Falastin, et al.
Publicado: (2021)

Decreased HLA-DQ expression on peripheral blood cells in children with varying number of beta cell autoantibodies
por: Andersson Svärd, Agnes, et al.
Publicado: (2020)

HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
por: Salami, Falastin, et al.
Publicado: (2022)

Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes
por: Larsson, Helena Elding, et al.
Publicado: (2013)

Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
por: Wang, Xin, et al.
Publicado: (2012)

Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD(65)-induced immune response
por: Tavira, Beatriz, et al.
Publicado: (2017)

An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011)

Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome
por: Gu Urban, Gucci Jijuan, et al.
Publicado: (2015)

Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
por: Axelsson, Stina, et al.
Publicado: (2011)

GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells
por: Arif, Sefina, et al.
Publicado: (2020)

Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
por: Hannelius, Ulf, et al.
Publicado: (2020)

Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2
por: Nowak, Christoph, et al.
Publicado: (2022)

Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
por: Axelsson, Stina, et al.
Publicado: (2013)

Impact of GAD65 and IA2 autoantibodies on islet allograft survival
por: Lemos, Joana R. N., et al.
Publicado: (2023)

Alum Pastilles
Publicado: (1860)

Alum as an Emetic
Publicado: (1854)

Is Alum Poisonous?
Publicado: (1879)

Alum in Pertusis
Publicado: (1847)

Alum as an Emetic
Publicado: (1854)

Bougies with Alum
Publicado: (1845)

Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D
por: Björklund, Anneli, et al.
Publicado: (2022)

GAD65 Autoantibody Responses in Japanese Latent Autoimmune Diabetes in Adult Patients
por: Maruyama, Taro, et al.
Publicado: (2008)

Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2β
por: Burbelo, Peter D., et al.
Publicado: (2010)

Evidence That HLA Class I and II Associations With Type 1 Diabetes, Autoantibodies to GAD and Autoantibodies to IA-2, Are Distinct
por: Howson, Joanna M.M., et al.
Publicado: (2011)

GAD65 autoantibodies and glucose tolerance in offspring born to women with and without type 1 diabetes (The EPICOM study)
por: Knorr, Sine, et al.
Publicado: (2021)

Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
por: Ng, Kenney, et al.
Publicado: (2022)

How alum works
por: Bashyam, Hema
Publicado: (2008)

Alum Injection for Dysentery
Publicado: (1890)

Ammonia Iron Alum
por: Kemp,, et al.
Publicado: (1868)

Alum in Typhoid Fever
Publicado: (1888)

Alum Baking Powders
Publicado: (1914)

Iron and Alum Mass
Publicado: (1877)

Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes
por: Barcenilla, Hugo, et al.
Publicado: (2022)

An Experimental Study of the Anti-oxidant and the Anti-inflammatory Effects of Alum and Burnt Alum
por: Seo, Hyung-Sik
Publicado: (2012)

Catatonic Schizophrenia Associated With Cerebrospinal GAD65 Autoantibodies: Case Report and Literature Review
por: Hansen, Niels, et al.
Publicado: (2022)

Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes
por: Williams, Alistair J.K., et al.
Publicado: (2015)

Influence of early-life parental severe life events on the risk of type 1 diabetes in children: the DiPiS study
por: Lundgren, Markus, et al.
Publicado: (2018)

Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study
por: Lundgren, Markus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lbeddojctpfdl42721qkv5m8ui